Simple blood test could predict Lymphoma's return
NCT ID NCT07480837
Summary
This study aims to see if tracking tiny pieces of tumor DNA in the blood can help predict how well lymphoma treatment is working and whether the cancer might come back. Researchers will collect blood samples from 60 patients with B-cell non-Hodgkin lymphoma before, during, and after their standard treatment. They will compare the blood test results to standard PET-CT scans to see if the blood test can reliably show how patients are responding.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL NON HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, China
Conditions
Explore the condition pages connected to this study.